| Purpose | Announcement Date | Split Date | Record Date | Face Value (before split) | Face Value (after split) |
|---|---|---|---|---|---|
| Split | 28 Feb 2024 | 30 May 2024 | 30 May 2024 | 10 | 2 |
| BALAXI PHARMACEUTICALS LIMITED has informed the Exchange that the Board of Directors at its meeting held on February 28, 2024, has considered and approved subdivision of 1 equity shares of 10 each into 5 equity shares of 2 each. Sub: Change in ISIN - Balaxi Pharmaceuticals Limited (BALAXI) Members of the Exchange are hereby informed that the ISIN Code for the equity shares of the following company shall be changed w.e.f. May 30, 2024. Symbol BALAXI Company Name Balaxi Pharmaceuticals Limited New ISIN INE618N01022 Remarks Sub-Division from Rs. 10/- to Rs. 2/- The new ISIN shall be effective for all trades done on and from the Ex-date date i.e., May 30, 2024. For and on behalf of National Stock Exchange of India Limited. | |||||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
